Skip to content

Renegade™ M001182530Recalls & reported problems

Boston Scientific Corporation · Fiber Braided Microcatheter · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729322832), received between Aug 31, 2018 and Jan 23, 2024 — classified as 4 malfunctions.

The most frequently reported specific device problem is “Break” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 1 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break2
  • Device Contaminated During Manufacture or Shipping1
  • Material Perforation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1
  • No Consequences Or Impact To Patient1
  • No Known Impact Or Consequence To Patient1
  • No Patient Involvement1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 23, 2024Device Contaminated During Manufacture or Shipping; Device Contaminated During Manufacture or Shipping

    IT WAS REPORTED THAT DEVICE CONTAMINATION OCCURRED. A 50/20/1TIP RENEGADE MICROCATHETER WAS SELECTED FOR USE. HOWEVER, WHEN THE STERILE TECH OPENED THE PACKAGE AND WENT TO TAKE THE CATHETER, A HAIR WAS SEEN INSIDE THE PACKAGE. THERE WAS NO PATIENT OR PROCEDURE INVOLVED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18565524 ↗
  • MalfunctionOct 5, 2020Break; Break

    IT WAS REPORTED THAT A CATHETER BREAK OCCURRED. A RENEGADE CATHETER WAS SELECTED FOR USE. DURING REMOVAL FROM THE PACKAGING, THE CATHETER SURFACE WAS HYDRATED LESS THAN 30 SECONDS PRIOR TO REMOVAL FROM THE CARRIER HOOP. RESISTANCE WAS FELT DURING FIRST TRIAL OF REMOVAL AND IT WAS NOTED THAT THE CATHETER BECAME SEPARATED. THE DEVICE WAS NEVER INSERTED INTO THE PATIENT. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10627522 ↗
  • MalfunctionAug 22, 2019Break; Break

    IT WAS REPORTED THAT THE CATHETER BROKE. A 150/20/1TIP RENEGADE WAS SELECTED FOR USE IN A PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) PROCEDURE. DURING UNPACKING, THE DISTAL PART OF THE CATHETER BROKE. THE PROCEDURE WAS COMPLETED WITH ANOTHER RENEGADE DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Patient Involvement

    MAUDE report 8921933 ↗
  • MalfunctionAug 31, 2018Material Perforation; Material Perforation

    IT WAS REPORTED THAT THERE WAS A HOLE IN THE SHAFT. A 150/20/1 RENEGADE WAS SELECTED FOR USE. DURING PREPARATION, A HOLE WAS NOTED IN THE OUTER SHAFT. NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 7837897 ↗

Other Catheter, continuous flush devices

All Catheter, continuous flush devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page